More investment needed on Medical Research, says Kiran Mazumdar Shaw
Mangaluru: Biocon Limited Chairperson Kiran Mazumdar Shaw on Wednesday stressed the urgent need for increasing investment on Medical Research in order to deal with the onslaught of diseases like Covid19 and non communicable diseases like diabetes and cancer.
"A country like India should consider Science and Technology as a priority area of investment in its national agenda and economic development", she added in her address at the Tenth Convocation of Yenepoya (Deemed to be University), held virtually today.
She said, "Covid-19 has cast a spotlight on the medical fraternity as the most valuable resources for the country in the healthcare sector. The doctors should inspire society in terms of research."
Many of the discoveries made decades ago by the Nobel Laureates in medicine are relevant even today. These discoveries have transformed medicine and the health care system around the world. India needs to focus on medical research, she stressed.
"The previous nine months witnessed the largest number of clinical trials, the largest medical publications and research programmes in the country. This clearly shows that we have potential in research and innovation. Clinical research is an integral part of drug development. For a country like India, the focus should be on delivering affordable innovation," Shaw said.
Medical research fraternity should build public trust. The Covid-19 vaccine provides an opportunity to build public trust. Sharing clinical data transparently in the public domain is essential to earn the public trust, she added.
Next Story